Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment

• Per Johansson,

  Affiliations Department of Neuropsychiatry, Skaraborg Central Hospital, Falköping, Sweden, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  ⨯
• Erik G. Almqvist,

  Affiliation Department of Endocrinology, Skaraborg Central Hospital, Skövde, Sweden

  ⨯
• Anders Wallin,

  Affiliation Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden

  ⨯
• Jan-Ove Johansson,

  Affiliation Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  ⨯
• Ulf Andreasson,

  Affiliation Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden

  ⨯
• Kaj Blennow,

  Affiliation Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden

  ⨯
• Henrik Zetterberg,

  Affiliations Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden, UCL Institute of Neurology, Queen Square, London, United Kingdom

  ⨯
• Johan Svensson

  * E-mail: johan.svensson@medic.gu.se

  Affiliations Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, Department of Endocrinology, Skaraborg Central Hospital, Skövde, Sweden

  http://orcid.org/0000-0002-4487-6405

  ⨯